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Does Rubidium-82 PET Have Superior Accuracy
to SPECT Perfusion Imaging for the
Diagnosis of Obstructive Coronary Disease?
A Systematic Review and Meta-Analysis
Brian A. Mc Ardle, MB, BCH,* Taylor F. Dowsley, MD,* Robert A. deKemp, PHD,*
George A. Wells, PHD,† Rob S. Beanlands, MD*
Ottawa, Ontario, Canada
Objectives The purpose of this study was to evaluate the accuracy of rubidium (Rb)-82 positron emission tomography (PET)
for the diagnosis of obstructive coronary artery disease (CAD) in comparison to single-photon emission tomogra-
phy (SPECT).
Background Myocardial perfusion imaging is widely used in the assessment of patients with known or suspected CAD. PET
using Rb-82 has potential advantages over SPECT that may make it more accurate and that reduce radiation
exposure compared with SPECT but has increased costs. Comparisons of these technologies are highly relevant
for policy makers and practice guidelines. However, studies directly comparing Rb-82 PET with contemporary
SPECT have been limited.
Method The authors therefore undertook a systematic review of studies where either Rb-82 PET or technetium-99m SPECT
with both attenuation correction and electrocardiography-gating were used as a diagnostic test for obstructive CAD
with invasive coronary angiogram as a reference standard. These technologies were then compared.
Results Fifteen PET and 8 SPECT studies (1,344 and 1,755 patients, respectively) met inclusion criteria and pooled ac-
curacy using weighted averages according to the size of the patient population was determined for PET and
SPECT with sensitivities of 90% (confidence interval [CI]: 0.88 to 0.92) and 85% (CI: 0.82 to 0.87) and specifici-
ties of 88% (CI: 0.85 to 0.91) and 85% (CI: 0.82 to 0.87), respectively. Summary receiver-operating characteristic
curves were computed: area under the curve was 0.95 and 0.90 for PET and SPECT, respectively (p 0.0001). There was
heterogeneity among study populations and some studies were limited by referral bias.
Conclusions Rb-82 PET is accurate for the detection of obstructive CAD and, despite advances in SPECT technology, remains
superior. More widespread use of Rb-82 PET may be beneficial to improve CAD detection. (J Am Coll Cardiol
2012;60:1828–37) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.07.038Positron emission tomography (PET) is a well-established
modality for the diagnosis and risk-stratification of patients
being assessed for coronary artery disease (CAD). However,
its availability remains limited due to costs relative to other
noninvasive imaging modalities. Compared with other nu-
clear methods for perfusion imaging, PET has several
From the *Molecular Function and Imaging Program, National Cardiac PET Centre,
Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario,
Canada; and the †Cardiac Research Methods Centre, University of Ottawa Heart
Institute, Ottawa, Ontario, Canada. This systematic review was supported in part by
the Cardiac Care Network of Ontario and Cardiac PET Subcommittee of the
Ontario PET Steering Committee. This work was also supported in part by the
Molecular Function and Imaging (MFI) Program (Program Grant from the Heart
and Stroke Foundation of Ontario [HSFO Grant #PRG6242]). Dr. Beanlands is a
Career Investigator supported by the Heart and Stroke Foundation of Ontario and a
tier 1 University of Ottawa Chair in Cardiovascular Research. Dr. Mc Ardle is
supported in part by the Molecular Function and Imaging Heart and Strokeadvantages, namely, accurate reliable attenuation correction
(AC), increased count sensitivity, and lower radiation dose.
The American College of Cardiology/American Heart
Association/American Society of Nuclear Cardiology guidelines
from 2003 give a Class I recommendation for the use of
PET myocardial perfusion imaging (MPI) for the diagnosis
Foundation of Ontario Program Grant (#PRG6242). Drs. Beanlands and deKemp
are consultants with Jubilant DRAXImage and have received grant funding from
a government/industry program (partners: GE Healthcare, Nordion, Lantheus
Medical Imaging, DRAXImage). Dr. deKemp receives revenues from rubidium
generator technology licensed to Jubilant DRAXImage. Dr. Beanlands is a
consultant for Lantheus Medical Imaging and has received grant funding from
Genentech. All other authors have reported that they have no relationships
relevant to the contents of this paper to disclose. Drs. Beanlands and Wells are
co-senior authors of this work.Manuscript received June 4, 2012; revised manuscript received June 29, 2012,
accepted July 10, 2012.
n
0
h
o
w
1829JACC Vol. 60, No. 18, 2012 Mc Ardle et al.
October 30, 2012:1828–37 Systematic Review Comparing PET and SPECT Perfusion Imagingof patients with an intermediate likelihood of CAD and/or
risk stratification of patients with an intermediate to high
likelihood of CAD in the setting of a prior equivocal
SPECT scan (level of evidence: B) and a Class IIa recom-
mendation for its use as the initial test in patients who
cannot exercise or who have baseline left bundle branch
block or electronic pacing (level of evidence: B) (1). Subse-
quently, American Society of Nuclear Cardiology guidelines
have not reconsidered the class of recommendation for PET
MPI. Studies that compare PET with other modalities,
particularly single-photon emission computed tomography
(SPECT), are limited and do not incorporate recent ad-
vances in SPECT technology such as electrocardiography
(ECG)-gating and AC using either computed tomography
(CT) or transmission sources.
We therefore performed this systematic review with the
aim of assessing the diagnostic accuracy of rubidium
(Rb)-82 PET for the assessment of patients with known or
suspected obstructive CAD in comparison with the refer-
ence standard invasive coronary angiography (ICA). We also
conducted a comparison with contemporary SPECT technol-
ogy utilizing ECG-gating and AC methods.
Methods
We previously performed a comprehensive systematic re-
view of PET perfusion imaging for diagnosis and prognosis
of patients with known or suspected obstructive CAD as
part of a review of multiple advanced noninvasive modali-
ties. This was performed on behalf of the Canadian Car-
diovascular Society (2) and included studies on Rb-82 PET
published up to 2006. We also incorporated a systematic
review of cardiac SPECT performed by the Ontario Min-
istry for Health that included studies published up to 2009
(3). We then performed a literature search across Ovid
MEDLINE, MEDLINE In-Process and Other Non-
indexed Citations, Ovid HealthSTAR, Embase, and the
Cochrane Library using updated versions of the search
strategies utilized in the 2 previous reviews that was limited
to articles published after January 2005 for PET and after
January 2008 for SPECT (Online Appendix). The last
search date was March 14, 2012.
The online contents of 6 highly relevant journals, Journal
of the American College of Cardiology (JACC), JACC: Cardio-
vascular Imaging, Circulation, Circulation Cardiovascular Im-
aging, Journal of Nuclear Medicine, and Journal of Nuclear
Cardiology, published in February and March 2012, were
also reviewed for relevant articles published online only.
Reference lists from several highly relevant articles were also
examined for relevant studies not obtained from the elec-
tronic search.
Two reviewers (B.M. and T.D.) assessed abstracts inde-
pendently for adherence to inclusion criteria. Full-text
articles were then obtained and examined for quality. If
there was disagreement regarding inclusion, a third-party devaluation was to be performed
to reach a consensus, although
this situation did not arise.
Inclusion criteria were prospective
studies, observational studies, retro-
spective studies, and case series pub-
lished in peer-reviewed journals; in-
volving humans; using either Rb-82
PET, or technetium (Tc)-99m
SPECT with both ECG-gating
and AC with either CT or transmis-
sion sources as an imaging modality
where ICA was used as a reference
standard for diagnosis of obstructive
CAD.
Only studies where data was
available to calculate true positives,
true negatives, false positives, and
false negatives and where accuracy
data was reported on a per-patient
basis (as opposed to by segment)
were included.
Exclusion criteria were ab-
stracts and trials involving pa-
tients with nonischemic heart
disease.
Subgroup analyses. Both Rb-82
PET and Tc-99m studies were compared according to the
ICA reference (50% vs.70% stenosis) as well as the type
of AC used (CT or transmission sources). Studies that excluded
patients with known CAD were also examined separately.
Statistical analysis. Absolute numbers for true positives,
false positives, false negatives, and true negatives were
extracted from the included papers. Ten studies included
patients that had a 5% statistical risk of CAD in their
results (Rb-82 PET [4–9], n  174; SPECT [10–14], n 
510) and these were included in our analysis as equivalent to
having a negative ICA.
Using extracted values, pooled accuracy data was obtained
using weighted averages according the size of the patient
population. Pooled estimates of likelihood ratio (LR) and
diagnostic odds ratio (DOR) were calculated using the
DerSimonian-Laird method based on the random effects
model. All accuracy estimates were reported by patient, not
by artery segment, with 95% confidence intervals (CIs).
Studies reporting obstructive CAD by location or multives-
sel disease were simplified to any CAD stenosis.
Heterogeneity between studies was assessed on Forest
Plots using the Cochran Q test and the Inconsistency Index
(I2). I2 describes the percentage variance due to heteroge-
eity rather than chance across the included studies with
%, 25%, 50%, and 75% indicating no, low, moderate, and
igh heterogeneity, respectively. Summary receiver-
perating characteristic (SROC) curves were also computed
ith area under the curve (AUC) reported as a measure of
Abbreviations
and Acronyms
AC  attenuation
correction
AUC  area under the
curve
CAD  coronary artery
disease
CI  confidence interval
CT  computed
tomography
DOR  diagnostic odds
ratio
ECG  electrocardiography
ICA  invasive coronary
angiography
LR  likelihood ratio
MPI  myocardial perfusion
imaging
PET  positron emission
tomography
SPECT  single-photon
emission computed
tomography
SROC  summary receiver-
operating characteristiciagnostic accuracy. The shape of the curve was on the basis
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The previous analyses were performed using Meta-DiSc
version 1.4 (Clinical Biostatistics Unit, Ramo´n y Cajal
Hospital, Madrid, Spain).
Between-study comparisons were made by combining all
available Rb-82 PET and SPECT studies with ICA as a
reference. AUC values were compared using a 2-tailed t test
with a p value 0.05 determining statistical significance.
Quality of evidence. The quality of the included studies
was assessed using the QUADAS questionnaire, a system-
atically developed assessment tool for use in systematic
reviews of diagnostic studies (15), which consists of 14
questions. This was performed using Cochrane’s Review
Manager software (version 5.1.6, Cochrane Collaboration,
Copenhagen, Denmark), which reports 11 of the questions,
to which the answer is either “yes,” “no,” or “unclear.” These
questions address bias, variability, and the quality of study
reporting.
Figure 1 Flow Diagram Showing the Results of the Systematic
Results for both Rb-82 positron emission tomography (PET) (left) and Tc-99m sing
cesses and final number of studies included. ¶Refers to Beanlands et al. (2); §ref
diography; MPI  myocardial perfusion imaging.Results
Literature search results. For Rb-82 PET a total of 1,570
citations were obtained from the electronic search of articles
published from January 1, 2006, to January 20, 2012. After
examination of the abstracts, 21 full-text articles were
obtained, of which 7 (5–9,16,17) met inclusion criteria.
Thirteen articles were omitted primarily because ICA was
not used as a reference. Two studies where both Rb-82 and
ammonia were used were not included as the results for the
Rb-82 patients alone could not be determined from the text
(18,19).
From the 2006 review a total of 6 studies were included
(4,20–24) that utilized Rb-82 PET. A 1992 study by
Marwick et al. examining the diagnostic accuracy of Rb-82
PET in patients with previous CABG (25) that was not
included in the 2006 review was found in the review of
reference lists and was also included for analysis. Review of
the online journal contents yielded 1 study for inclusion
ew
ton emission computed tomography (SPECT) (right) showing exclusion pro-
Medical Advisory Secretariat (3). AC  attenuation correction; ECG  electrocar-Revi
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patients analyzed (Fig. 1).
For SPECT, 537 citations were obtained from the
electronic search of articles published from January 1, 2008,
to March 14, 2012. From these 10 full-text articles were
obtained, of which 3 met inclusion criteria (10,13,14). From
the previous systematic review we extracted citations for 12
full-text articles that were examined, of which 4 (12,27–29)
were included. Examination of reference lists yielded 1
further study for inclusion (11) (Fig. 1).
Trial characteristics. All trials assessing Rb-82 were pub-
ished between January 1990 and November 2011 and those
or SPECT were published between May 2000 and July
011 and all were either prospective or retrospective obser-
ational studies. There was heterogeneity between studies
egarding the prevalence of obstructive CAD as well as the
iagnostic criteria for a positive ICA (see Table 1). The
majority of patients were male and the mean age overall was
61.75 (95% CI: 58.95 to 64.38) for Rb-82 PET and 61.1
(95% CI: 59.1 to 63.2) for Tc-99m SPECT. For SPECT,
the majority of studies utilized both exercise and pharma-
cological stress, so both were included in the analysis.
Diagnostic accuracy of Rb-82 PET. The overall pooled
sensitivity of Rb-82 PET for the detection of obstructive CAD
was 90% (95% CI: 0.88 to 0.92), with specificity of 88% (95% CI:
0.85 to 0.91) (Fig. 2). The pooled positive LR for diagnosis of
significant CAD was 5.57 (95% CI: 4.02 to 7.75) with a pooled
DOR of 56.73 (95% CI: 37.99 to 84.71). The SROC curve
analysis showed an AUC of 0.95 (Fig. 3).
Referral bias for the use of ICA in the majority of studies may
have had an adverse impact on overall specificity and so the
concept of a normalcy rate in patients statistically at low (5%)
risk for CAD was also explored on the basis of Bayesian
analysis of baseline characteristics. In 5 studies, Rb-82 PET
was found to correspond well with expected results (130
patients) with a pooled normalcy rate of 96% (95% CI: 0.91 to
0.99) (7–9,30). One other study included low-likelihood CAD
risk patients (5%) but did not report a normalcy rate (5).
Characteristics of Rb-82 PET and Tc-99m SPECTable 1 Characteristics of Rb-82 PET and T
Study Characteristics Rb-
Total patients 1
Mean age, yrs 61.75 (5
Males, % 854 (6
Mean BMI 30 (2
CAD prevalence, % (without LLR patients) 63% (7
LLR patients, % 174 (1
Previous MI 399 (3
Previous PCI/CABG 424 (3
Transmission AC 787 (5
CT AC 557 (4
Values are n, mean (95% confidence interval [CI]), n (%), or % (n).
AC  attenuation correction; BMI  body mass index; CABG  cotomography; LLR  low likelihood ratio; MI  myocardial infarction; PCI
tomography; SPECT  single-photon emission computed tomography.Excluding low LR patients (n  1,170) did not have a
ignificant effect on overall accuracy (AUC: 0.94, p  0.73)
with a small decrease in specificity to 86% (95% CI: 0.82 to
0.90). Comparison of studies where 50% stenosis on
ICA was used as a reference with 70% showed no
significant difference in diagnostic accuracy (AUC: 0.948
vs. 0.954, respectively; p  0.78) (Table 2). Three studies
reported values for both 50% and 70% (7,9,26) and both
data sets were analyzed. Comparison of CT and trans-
mission AC did not show any significant difference in
accuracy (p  0.19) (Table 2).
Including only studies with patients with no documented
CAD (n  297) did not increase overall accuracy signifi-
cantly compared to studies including patients with previous
myocardial infarction or revascularization but specificity did
improve from 87% to 91%.
The I2 values for sensitivity and DOR were 14.8% and 0%
respectively, indicating little or no heterogeneity amongst
studies for these parameters. However, the values for specificity
(68.4%) and positive LR (41.7%) indicated a more significant
degree of variance.
Diagnostic accuracy of SPECT. Sensitivity and specificity
for Tc-99m SPECT with ECG-gating and AC were 85%
(95% CI: 0.82 to 0.87) and 85% (95% CI: 0.82 to 0.87),
respectively, with an AUC of 0.90. Subgroup analysis
showed that accuracy for a 50% stenosis on ICA was
superior to 70% (AUC: 0.91 and 0.87, respectively; p 
0.0001) (Table 3). The I2 values for sensitivity, DOR,
pecificity, and positive LR were 46.5%, 48.5%, 54.2%, and
8.2%, respectively, which indicates a moderate degree of
ariance for each parameter.
Analysis of studies where patients with known CAD or
revious myocardial infarction were excluded (n  1,320
atients) did not alter diagnostic accuracy significantly. Four
tudies (10,12–14) reported a normalcy rate (n  461
atients) with a pooled normalcy rate of 97% (95% CI: 0.95
o 0.98), which was similar to Rb-82 PET.
dies Included in AnalysisSPECT Studies Included in Analysis
T Tc-99m SPECT
2-Tailed t Test
p Value
1,755
4.38) 61.1 (59.1–63.2) 1.1
969 (55%) 0.002
30 (28–32) 1.1
50% (68%) 0.002 (0.008)
530 (30%) 0.002
60 (3.4%) 0.002
56 (3.2%) 0.002
1,678 (95.7%) 0.002
77 (4.3%) 0.002
artery bypass graft; CAD  coronary artery disease; CT  computedT Stuc-99m
82 PE
,344
8.95–6
3.5%)
9–31)
2%)
3%)
0%)
2%)
9%)
1%)
ronary
 percutaneous coronary intervention; PET  positron emission
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was a marked decrease in specificity (70%, 95% CI: 0.66 to
0.75) with an AUC of 0.86.
Comparison with Rb-82 PET showed superior accuracy
of PET overall (p  0.0001) with a more pronounced
ifference when low LR patients were excluded. Subgroup
nalysis showed that the difference in AUC between PET
nd SPECT for studies with a 50% ICA reference stenosis
id not reach statistical significance. However, the preva-
ence of CAD within this subgroup was significantly higher
or Rb-82 PET than SPECT (81.9% vs. 54.1%).
Four of the included Rb-82 studies performed a direct
omparison with SPECT but 3 of these used thallium
Tl)-201 (20,23,25) and the study using Tc-99m did not use
C (4). Pooled analysis of these studies also demonstrated
uperior accuracy of PET (Fig. 4). However, this compar-
son may have limited relevance for current practice in the
ajority of centers that do not use Tl-201.
uality of studies. The result of the QUADAS analysis of
Figure 2 Forest Plots Showing Sensitivities and Specificities o
Tc-99m SPECT Studies Included in the Analysis With
Pooled results from individual Rb-82 PET (A) and Tc-99m SPECT (B) are also show
and specificity (88% vs 85%). CI  confidence interval; PET  positron emission the included studies is shown in Figure 5. A large propor- aion of both Rb-82 PET (10 of 15) and Tc-99m SPECT (5
f 8) studies were affected by referral bias whereby the
eferral for ICA may have been influenced by the results of
he perfusion scan. In 4 of 15 PET (7,9,24,25) and 6 of 8
10,11,13,14,27,28) SPECT studies it was unclear whether
he ICA results were blinded to the results of the perfusion
maging. Patient withdrawals and non-interpretable results
ere not reported in the majority of both SPECT and PET
tudies, primarily due their retrospective nature. Patient’s
linical information was not clearly available for image inter-
retation in any study, which, in effect, may result in a more
obust blinded examination of diagnostic accuracy for both
odalities. One study included only CABG patients (25) and
herefore did not have a representative spectrum of patients.
iscussion
o our knowledge, this is the most comprehensive
ystematic review and meta-analysis of the diagnostic
vidual Rb-82 PET and
CIs
Rb-8 PET showing superior sensitivity (90% vs. 85%)
aphy; SPECT  single-photon emission computed tomography.f Indi
95%
n with
omogrccuracy of Rb-82 PET that has been undertaken. A
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October 30, 2012:1828–37 Systematic Review Comparing PET and SPECT Perfusion Imagingprevious meta-analysis by Nandalur et al. (31) did not
focus on Rb-82, and rather combined tracers, namely
N-13-ammonia, Rb-82, and F-18-Fluorodeoxyglucose
(total 840 patients), making it difficult to determine the
utility of Rb-28 PET alone. The study, published in
2008, included only 8 of 15 Rb-82 PET studies analyzed
in the current systematic review and did not make a
Figure 3
SROC Curves for Diagnostic Accuracy of
Rb-82 PET and Tc-99m SPECT With
ECG-Gating and Attenuation Correction
Area under the curve (AUC) was compared for Rb-82 PET (A) and Tc-99m
SPECT (B), with Rb-82 PET showing superior accuracy (p  0.001). ECG 
electrocardiography; PET  positron emission tomography; Q  Cochran Q sta-
tistic; SPECT  single-photon emission computed tomography; SROC  sum-
mary receiver-operating characteristic.comparison to SPECT. They reported sensitivity andspecificity of 92% (95% CI: 0.9 to 0.94) and 85% (95%
CI: 0.79 to 0.90) for PET MPI overall (31).
A recently published meta-analysis from Jaarsma et al.
(32) compared PET and SPECT using all tracers and
protocols as well as cardiac magnetic resonance imaging.
However, they did not focus on Rb-82 PET, or on an
optimized SPECT protocol, as we have done. Furthermore,
none of the 8 SPECT studies and only 10 of 15 Rb-82 PET
studies included in this review were included in their
analysis, primarily because they were published after the
final search date of that review.
The current meta-analysis is timely, as there is renewed
interest in PET MPI and specifically Rb-82 as a radiotracer
following the recent molybdenum-99 shortage, the parent
compound of Tc-99m, and the recent recall (and subse-
quent reintroduction) of the Bracco diagnostics Rb-82
generators in the United States due to strontium break-
through.
While there are studies that directly compare Rb-82 PET to
SPECT, as noted, the comparison does not incorporate the
developments in SPECT that have occurred in recent years.
We included only SPECT studies that reflect current practice
in the majority of large centers and found that Rb-82 PET
continues to demonstrate superior diagnostic accuracy.
In addition, Rb-82 PET results in lower radiation expo-
sure than SPECT imaging with exposure estimates are 4- to
5-fold lower than Tc-99m–based SPECT (effective dose 2
to 3.7 mSv) (33–35).
A disadvantage of Rb-82 PET is increased cost relative to
SPECT MPI, with costs per scan estimated at USD$1,850
versus USD$1,000 in a 2007 study by Merhige et al. (36).
However, the decrease in false positive scans documented at
ICA (15.6% vs. 5.2%; p  0.001) in this study led to a 50%
decrease in downstream referral for ICA in the Rb-82 PET
group. This, in turn, led to the overall costs of patient
management using both modalities being identical when the
cost of increased use of ICA was considered. Moreover,
there was a trend toward better short-term outcomes in the
Rb-82 PET cohort.
Study limitations. The nonrandomized fashion in which
patients were referred for ICA may have resulted in referral
bias within many studies with the potential effect of increasing
the apparent test sensitivity while decreasing specificity. How-
ever, this affected both Rb-82 PET and SPECT studies
equally and was offset to a degree in several studies where
low-risk patients who did not undergo ICA were included for
analysis.
In several studies the ICA interpretation may not have
been blinded to the results of the perfusion scan, leading to
potential verification bias occurring with greater frequency
in the SPECT studies. However, analysis without these
studies did not have an adverse impact on accuracy for
Rb-82 PET. There were only 2 SPECT studies unaffected
by this and so a subgroup analysis was not performed.
The comparison between Rb-82 PET and SPECT is
indirect and involved pooling of data from trials of varying
ased at
l SPECT
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ning protocols and image interpretation, and patient popu-
lations were not matched in terms of baseline characteristics
such as gender or CAD prevalence, therefore these results
need to be interpreted with caution. The prevalence of
CAD was higher in Rb-82 PET studies, although it is
notable that the specificity of PET remained superior
despite this potential handicap. When low likelihood risk
patients were excluded, the difference in CAD prevalence
between PET and SPECT was decreased somewhat (72%
and 68%, respectively) and the difference in accuracy was
more pronounced in favor of Rb-82 PET (AUC: 0.94 vs.
0.86; p  0.0001). Furthermore, the ICA reference stenosis
varied between studies and while subgroup analysis showed
superior accuracy for Rb-82 PET for detection of both 50%
and 70% stenosis, this should also be taken into account
when interpreting the results.
Of the studies examining Rb-82 PET, 8 of 15 used
transmission sources for attenuation rather than the current
approach using CT. Subgroup analysis did show increased
specificity for attenuation correction performed with CT
(89% vs. 86%) but no significant difference in AUC. Also,
only 3 studies utilized 3-dimensional PET scanning, which
is now commonly employed in clinical practice (26,30,37).
While we examined several SPECT studies that utilized
CT-based AC (38–41), only 1 (29) met inclusion criteria,
primarily because the others did not incorporate both AC
and ECG-gated images into image interpretation.
Outline of Results of Meta-Analysis of Rb-82 PET DataTable 2 Outline of Results of Meta-Analysis of Rb-82 PET Data
Rb-82 PET Results
Sensitivity
(95% CI)
Specificity
(95% CI)
Po
(
PET overall (n  1.344) 90% (0.88–0.92) 88% (0.85–0.91) 5.57
50% ICA stenosis ref (n  917) 90% (0.87–0.92) 86% (0.81–0.90) 4.91
70% ICA stenosis ref (n  676) 92% (0.88–0.94) 86% (0.82–0.90) 5.49
Rb-82 PET with CTAC (n  557) 90% (0.86–0.93) 89% (0.85–0.93) 6.88
Rb-82 PET with transmission AC
(n  787)
90% (0.87–0.92) 86% (0.81–0.90) 4.95
PET studies with known CAD
excluded (n  297)
90% (0.84–0.94) 91% (0.84–0.95) 8.89
Values are % (95% CI) or integer values (95% CI). There was no significant difference in area und
(AC) was performed with computed tomography (CT) or transmission sources.
CAD  coronary artery disease; CI  confidence interval; CTAC  computed tomography–b
ikelihood ratio; PCI  percutaneous coronary intervention; PET  positron emission tomography;
Outline of SPECT Meta-Analysis ResultsTable 3 Outline of SPECT Meta-Analysis Results
Tc-99m SPECT Results
Sensitivity
(95% CI)
Specificity
(95% CI)
SPECT overall (n  1,755) 85% (0.82–0.87) 85% (0.82–0.87
SPECT ICA stenosis 50% (n  261) 82% (0.76–0.88) 89% (0.82–0.94
SPECT ICA stenosis 70% (n  1,494) 86% (0.83–0.88) 84% (0.81–0.87
SPECT studies with known CAD
excluded (n  1,320)
84% (0.81–0.87) 85% (0.82–0.88Values are % (95% CI) or integer values (95% CI).
Abbreviations as in Table 2.The current study did not consider the added information
that may be provided by left ventricular function or transient
ischemic dilatation (5,42–44), as these are inconsistently
reported in previous accuracy studies. This may underesti-
mate overall accuracy but would be expected to do so for
both PET and SPECT. Myocardial flow quantification was
also not part of the current study, as there are limited data
evaluating the diagnostic accuracy of this modality and the
studies that have been done are of varying design. We also
elected to not evaluate prognosis data because we are aware
that a separate combined analysis of prognosis data using
Rb-82 PET is currently underway (personal communica-
tion, S. Dorbala and L. Shaw, January 2012).
There is limited evidence that directly compares Rb-82
PET with other imaging modalities. However, there are
ongoing prospective studies. The European EVINCI
(EValuation of INtegrated Cardiac Imaging) study will
compare the diagnostic accuracy of functional imaging,
including PET, with anatomical imaging with CT, in
comparison with ICA. The rubidium ARMI (Alternative
Radiopharmaceutical for Myocardial Imaging) trial is a
prospective cohort study examining patients undergoing
Rb-82 3D PET with the aim of comparing diagnostic
accuracy and the cost-effectiveness of PET to both Tl-201–
and Tc-99m–based radiotracers SPECT using ICA as the
gold standard. These studies are ongoing and were not
available for this analysis.
LR
I)
DOR
(95% CI)
AUC
(Q Statistic) p Value
7.72) 56.73 (37.99–84.71) 0.95 (0.89)
6.95) 52.73 (32.13–86.52) 0.948 (0.89) 50% vs. 70% 0.78
8.69) 61.43 (35.57–106.09) 0.9549 (0.897)
12.27) 69.72 (34.80–139.69) 0.96 (0.90) CTAC vs. transmission AC
0.09
7.55) 50.81 (30.411–84.91) 0.94 (0.88)
32.09) 92.05 (18.54–456.98) 0.96 (0.90) 0.14 compared to studies
including known CAD
urve (AUC) whether a cutoff of 50% or 70% stenosis was used or whether attenuation correction
tenuation correction; DOR  diagnostic odds ratio; ICA  invasive coronary angiography; LR 
 single-photon emission computed tomography.
Positive LR
(95% CI)
DOR
(95% CI)
AUC
(Q Statistic)
p Value
Compared to
Rb-82 PET
5.13 (4.01–6.56) 28.29 (17.66–45.30) 0.900 (0.84) 0.0001
6.98 (3.88–12.58) 36.52 (15.54–85.1) 0.917 (0.85) 0.08
4.73 (3.58–6.26) 25.08 (13.3–47.30) 0.879 (0.81) 0.00001
5.01 (3.36–7.47) 23.83 (11.77–48.2) 0.895 (0.82) 0.0001sitive
95% C
(4.02–
(3.47–
(3.47–
(3.86–
(3.25–
(2.46–
er the c)
)
)
)
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In this systematic review and meta-analysis, Rb-82 PET
demonstrated sensitivity and specificity of 90% and 88% for
detection of obstructive coronary disease on ICA. Rb-82 PET
was demonstrated to have superior accuracy in comparison
with Tc-99m SPECT with both ECG-gating and AC. While
the comparison is indirect, this suggests that more widespread
use of Rb-82 PET may be beneficial to improve the accuracy
of noninvasive detection of obstructive CAD.
Figure 4 Forest Plots Showing Sensitivities and Specificities of S
Pooled results show superior accuracy of Rb-82 PET. However, three-quarters of studi
with none using attenuation correction (4,20,22,23). CI  confidence interval; PET 
Figure 5 Results of QUADAS Analysis Comparing the Methodol
Referral bias, whereby the results of the perfusion study influenced the decision to
Rb-82 PET (right) and 6 of 8 Tc-99m SPECT (left) studies the angiogram interpret
phy; SPECT  single-photon emission computed tomography.Acknowledgments
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APPENDIX
For an outline of the search strategies,
please see the online version of this article.
